Literature DB >> 17296736

Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.

Xiaozhe Wang1, Richard D Kennedy, Kallol Ray, Patricia Stuckert, Tom Ellenberger, Alan D D'Andrea.   

Abstract

The eleven Fanconi anemia (FA) proteins cooperate in a novel pathway required for the repair of DNA cross-links. Eight of the FA proteins (A, B, C, E, F, G, L, and M) form a core enzyme complex, required for the monoubiquitination of FANCD2 and the assembly of FANCD2 nuclear foci. Here, we show that, in response to DNA damage, Chk1 directly phosphorylates the FANCE subunit of the FA core complex on two conserved sites (threonine 346 and serine 374). Phosphorylated FANCE assembles in nuclear foci and colocalizes with FANCD2. A nonphosphorylated mutant form of FANCE (FANCE-T346A/S374A), when expressed in a FANCE-deficient cell line, allows FANCD2 monoubiquitination, FANCD2 foci assembly, and normal S-phase progression. However, the mutant FANCE protein fails to complement the mitomycin C hypersensitivity of the transfected cells. Taken together, these results elucidate a novel role of Chk1 in the regulation of the FA/BRCA pathway and in DNA cross-link repair. Chk1-mediated phosphorylation of FANCE is required for a function independent of FANCD2 monoubiquitination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296736      PMCID: PMC1899922          DOI: 10.1128/MCB.02357-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

Authors:  Ronit I Yarden; Sherly Pardo-Reoyo; Magda Sgagias; Kenneth H Cowan; Lawrence C Brody
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

2.  Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.

Authors:  B Xu; M B Kastan
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

3.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.

Authors:  Toshiyasu Taniguchi; Irene Garcia-Higuera; Paul R Andreassen; Richard C Gregory; Markus Grompe; Alan D D'Andrea
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

4.  Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach.

Authors:  Ted O'Neill; Lauren Giarratani; Ping Chen; Lakshmanan Iyer; Chang-Hun Lee; Matthew Bobiak; Fumihiko Kanai; Bin-Bing Zhou; Jay H Chung; Gary A Rathbun
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

5.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Isolation of a cDNA representing the Fanconi anemia complementation group E gene.

Authors:  J P de Winter; F Léveillé; C G van Berkel; M A Rooimans; L van Der Weel; J Steltenpool; I Demuth; N V Morgan; N Alon; L Bosnoyan-Collins; J Lightfoot; P A Leegwater; Q Waisfisz; K Komatsu; F Arwert; J C Pronk; C G Mathew; M Digweed; M Buchwald; H Joenje
Journal:  Am J Hum Genet       Date:  2000-09-19       Impact factor: 11.025

7.  The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.

Authors:  Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

8.  Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.

Authors:  Philip C Mack; David R Gandara; Alvin H Lau; Primo N Lara; Martin J Edelman; Paul H Gumerlock
Journal:  Cancer Chemother Pharmacol       Date:  2003-03-25       Impact factor: 3.333

9.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

10.  The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.

Authors:  Ethan A Kohn; Carolyn J Yoo; Alan Eastman
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

View more
  75 in total

1.  High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation.

Authors:  Ann Christin Parplys; Jasna Irena Seelbach; Saskia Becker; Matthias Behr; Agnieszka Wrona; Camilla Jend; Wael Yassin Mansour; Simon Andreas Joosse; Horst-Werner Stuerzbecher; Helmut Pospiech; Cordula Petersen; Ekkehard Dikomey; Kerstin Borgmann
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.

Authors:  Seok-Won Jang; Jin Ki Jung; Jung Min Kim
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

3.  UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination.

Authors:  Arno Alpi; Frederic Langevin; Georgina Mosedale; Yuichi J Machida; Anindya Dutta; Ketan J Patel
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

Review 4.  Expanded roles for Chk1 in genome maintenance.

Authors:  Greg H Enders
Journal:  J Biol Chem       Date:  2008-04-18       Impact factor: 5.157

5.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

6.  The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.

Authors:  David Polito; Scott Cukras; Xiaozhe Wang; Paige Spence; Lisa Moreau; Alan D D'Andrea; Younghoon Kee
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

7.  Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.

Authors:  M A Rego; J A Harney; M Mauro; M Shen; N G Howlett
Journal:  Oncogene       Date:  2011-06-20       Impact factor: 9.867

Review 8.  FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress.

Authors:  Yuliang Wu; Robert M Brosh
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

Review 9.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

10.  Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase.

Authors:  Halfdan Beck; Viola Nähse; Marie Sofie Yoo Larsen; Petra Groth; Trevor Clancy; Michael Lees; Mette Jørgensen; Thomas Helleday; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.